A variety of targeted anticancer agents have been successfully introduced into clinical
practice, largely reflecting their ability to inhibit specific molecular alterations that are …

Lung cancer is the most commonly diagnosed cancer and biggest cause of cancer mortality
worldwide with non-small cell lung cancer (NSCLC) accounting for most cases …

Abstract The coronavirus disease 2019 (COVID-19) pandemic is currently accelerating.
Patients with locally advanced NSCLC (LA-NSCLC) may require treatment in locations …

Recent studies have shown that a tumor's biological response to radiation varies over time
and has a dynamic nature. Dynamic biological features of tumor cells underscore the …

Abstract Background and Purpose Magnetic resonance-guided radiotherapy (MRgRT) with
real-time intra-fraction tumor motion monitoring allows for high precision Stereotactic …

Cancer stem cells (CSCs) are regarded as essential targets to overcome tumor progression
and therapeutic resistance; however, practical targeting approaches are limited. Here, we …

Purpose Treatment of fast-growing, human papillomavirus–negative, head and neck
cancers (HNCs) remains challenging from the perspectives of both tumor control and late …

Purpose: Vascular damage and inflammation are limiting toxic effects of lung cancer
radiotherapy, which lead to pneumonitis and pulmonary fibrosis. We have demonstrated that …

Purpose We launched a prospective phase 2 clinical trial to explore the safety and efficacy
of hypofractionated radiation therapy (hypo-RT) followed by hypofractionated boost (hypo …

Image guidance has been playing a decisive role throughout the history of radiotherapy, but
developments in 3D-and 4D imaging data acquisition using computed tomography (CT) …